Fundraising FoxGIE Medical
Plymouth, US · Founded 2018 · 1 known investors
Find your way into GIE Medical
Sign up to see every warm intro you have to GIE Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the GIE Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
GIE Medical is a clinical-stage medical device company developing the ProTractX3, a drug-coated balloon for treating benign strictures of the esophagus and bowel. It is conducting clinical trials in the United States aimed at offering gastroenterology patients sustained patency and fewer repeat treatments.
Founders & leadership
GIE Medical was founded in 2018 by Lixiao Wang.
LW
Lixiao WangFounder & Chief Executive OfficerLixiao Wang is founder and CEO of GIE Medical, a clinical-stage medical device company developing treatments for benign gastrointestinal strictures. He brings over 30 years of experience in medical device development and leadership.
JN
James NessChief Financial Officer
HM
Harrison MalinoffVP of Operations and Quality
DH
Dave HendricksonVP of Research & Development
Investors · 1
Reported raises · per SEC filings
Form D private placements$18M disclosed across 3 rounds · 2018–2023
▶$5MraisedSep 2023 · 1 investors · Other Health CareRule 506(b)
▶$5MraisedSep 2023 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ling ShangDirector
- Hui HuDirector
- Ouyang XiangyuDirector
- Lixiao WangExecutive Officer, Director, Promoter
- Rushu LuoDirector
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$11MraisedFeb 2021 · 33 investors · Other Health CareRule 506(b)
▶$11MraisedFeb 2021 · 33 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Lixiao WangExecutive Officer, Director, Promoter
- Offering amount
- $32.9M
- Amount sold
- $11M
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$2MraisedAug 2018 · 1 investors · Other Health CareRule 506(b)
▶$2MraisedAug 2018 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Lixiao WangExecutive Officer, Director, Promoter
- Offering amount
- $4.1M
- Amount sold
- $2M
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
Boston ScientificBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
LaborieLaborie develops medical devices and solutions for women's health, including technologies to manage complications like postpartum hemorrhage.
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies working in the same space as GIE Medical.
Frequently asked questions
- What does GIE Medical do?
- GIE Medical is a clinical-stage medical device company developing the ProTractX3, a drug-coated balloon for treating benign strictures of the esophagus and bowel. It is conducting clinical trials in the United States aimed at offering gastroenterology patients sustained patency and fewer repeat treatments.
- Who founded GIE Medical?
- GIE Medical was founded by Lixiao Wang in 2018.
- Who are GIE Medical's investors?
- GIE Medical's investors include HM Venture Partners.
- How much funding has GIE Medical raised?
- GIE Medical has disclosed $18M raised across 3 rounds.
- Where is GIE Medical headquartered?
- GIE Medical is headquartered in Plymouth, US.